<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>0</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>05</Month>
        <Day>24</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Clinical and Immune Features of Pneumocystis Pneumonia with Acute Respiratory Distress Syndrome in Immunocompromised Children</title>
    <FirstPage>1</FirstPage>
    <LastPage>15</LastPage>
    <AuthorList>
      <Author>
        <FirstName>DongDong</FirstName>
        <LastName>Feng</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University, Nanning, Guangxi Zhuang Autonomous Region, China</affiliation>
      </Author>
      <Author>
        <FirstName>Chao</FirstName>
        <LastName>Chen</LastName>
        <affiliation locale="en_US">Pediatric Intensive Care Unit (PICU), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>HuiMin</FirstName>
        <LastName>Huang</LastName>
        <affiliation locale="en_US">Pediatric Intensive Care Unit (PICU), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>XueQiong</FirstName>
        <LastName>Huang</LastName>
        <affiliation locale="en_US">Pediatric Intensive Care Unit (PICU), The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>10</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Pneumocystis jirovecii pneumonia (PJP) is a common opportunistic infection in immunocompromised children, often causing acute fulminant pneumonia with respiratory failure. The prognosis of PJP in human immunodeficiency virus (HIV)-negative children with acute respiratory distress syndrome (ARDS) remains unclear.
This retrospective review (2015&#x2013;2021) included 20 HIV-negative children with ARDS and PJP. Among them, 17 had hematological malignancies or solid tumors, and 3 had renal disease; 15 survived, 5 did not. Both groups had very low CD4+ T cell counts (&lt;0.2&#xD7;10&#x2079;/L), severe ARDS (partial pressure of oxygen in arterial blood / fraction of inspired oxygen [PaO&#x2082;/FiO&#x2082;] ratio &lt;150), and elevated lactate dehydrogenase (LDH) and (1,3)-&#x3B2;-D-glucan (BDG) levels. In non-survivors, anti-PJP therapy was initiated approximately 7 days later than in survivors.
Single-cell sequencing revealed CD4+/CD8+ T cell ratios of 0.16 (survivors) vs 2.13 (non-survivors), with a higher ratio of regulatory T cells (Tregs) to CD4&#x207A; T cells in non-survivors (33% vs. 10.6%). Non-survivors showed enrichment of neutrophil degranulation and activation pathways and expressed more proapoptotic and proinflammatory signals (e.g., FAS_FASLG, interferon-&#x3B3;).
Early treatment initiation is critical. Prolonged CD8+ T cell deficiency, high Treg expression with proapoptotic genes, and excessive inflammation may predict poor prognosis.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4506</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4506/2348</pdf_url>
  </Article>
</Articles>
